Show metadata Hide metadata

(19)

(11)

2 663 913

(13)

(51)

IPC

A61K31/4412(2006-01-01)

A61K31/444(2006-01-01)

A61K47/04(2006-01-01)

A61K47/26(2006-01-01)

A61K47/32(2006-01-01)

A61K47/38(2006-01-01)

A61K9/20(2006-01-01)

(21) (22)

Application

2016145107, 2016-11-17

(24)

Start date

2016-11-17

(22)

Actual filing date

2016-11-17

(45)

Published

2018-08-13

(72)

Inventor

Danilenko Valerij NikolaevichBekker Olga BorisovnaMorozov Aleksej SergeevichRadchenko Evgenij ValerevichPalyulin Vladimir AleksandrovichMalykhin Maksim Denisovich

(73)

Holder

Avtonomnaya Nekommercheskaya Organizatsiya Tsentr Biotekhnologii Antibiotikov I Drugikh Biologicheski Aktivnykh Veshchestv

SOLID DOSAGE FORM OF ANTIDIABETIC DRUG BASED ON N-SUBSTITUTED DERIVATIVE AMRINONE - KINASE INHIBITOR OF GLUCOGEN SYNTHASE Russian patent published in 2018 - IPC A61K31/4412 A61K31/444 A61K47/04 A61K47/26 A61K47/32 A61K47/38 A61K9/20

Abstract RU 2663913 C1

FIELD: medicine.

SUBSTANCE: invention relates to medicine, specifically to agents for the treatment of type II diabetes. Essence of the invention consists in the creation of a solid dosage form of an antidiabetic drug based on the N-substituted derivative amrinone-kinase inhibitor of glycogen synthase 4-methoxy-N-(6-oxo-1,6-dihydro-3,4'-bipyridine-5-yl)benzamide 1, containing active substance 1 and excipients in the ratio indicated in the claims.

EFFECT: new solid dosage form expands the range of antidiabetic agents.

13 cl, 4 ex

Similar patents RU2663913C1

Title	Year	Author	Number
3-ACYLAMINOPYRIDIN DERIVATIVES, APPLICABLE AS SERINE-THREONINE PROTEINKINASE GSK3B INHIBITORS, AS MEDICATIONS FOR TYPE II DIABETES TREATMENT	2013	Alekseeva Marija Georgievna Danilenko Valerij Nikolaevich Zefirov Nikolaj Serafimovich Mavletova Dilara Anvarovna Morozov Aleksej Sergeevich Osolodkin Dmitrij Ivanovich Paljulin Vladimir Aleksandrovich	RU2570907C2
CITRIC SALT OF INDOLE DERIVATIVE, METHOD FOR PRODUCING THEREOF, ADMINISTERING THEREOF AND BASED PHARMACEUTICAL COMPOSITION	2007	Berg Anna-Lena Bkheht Rehtan Sebkhatu Tesfai Stokhle Ehrika	RU2415137C2
PHARMACEUTICAL ACTIVE INGREDIENT AND ITS APPLICATION, IN PARTICULAR FOR PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS	2018	Peltier Sebastien Chavanelle Vivien Le Joubioux Florian Sirvent Pascal Maugard Thierry	RU2759903C2
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF	2018	Mashevskaya Irina Vladimirovna Suldin Aleksandr Sergeevich Puchnina Svetlana Vladimirovna	RU2688235C1
AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES	2010	Biftu Tesfaje Chehn' Pin Fehn Dan'Tsin Tsjan' Sjaosja	RU2550508C2
APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION	2006	Bal'Kan Berk Kholms Dejvid Grenvill Kh'Juz Tomas Ehduard Villkhoer Ehduin Bernard	RU2440143C2
BENZIMIDAZOLE DERIVATIVE AND USE AS ANGIOTENSIN II ANTAGONIST	2006	Kuroita Takanobu Odzima Mami Ban Dzjunko	RU2407742C2
PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID	2016	Chuev Vladimir Petrovich Buzov Andrej Anatolevich Kovalenko Sergej Nikolaevich Merzlikin Sergej Ivanovich Shtrygol Sergej Yurevich	RU2624872C1
ANTIDIABETIC PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING	1999	Vejbel' Khelle Jort Tjuge Borup	RU2233659C2
HYDROBROMID 4'-(2,3-DIGIDRO-9H-IMIDAZO[1,2-A]BENZIMIDAZOLE-9-YL-METHYL)BIPHENYL-2-CARBONITRIL EXHIBITING THE PROPERTIES OF THE ACTIVATOR OF AMP-ACTIVATED PROTEINKINASE (AMPA)	2017	Zhukovskaya Olga Nikolaevna Spasov Aleksandr Alekseevich Babkov Denis Aleksandrovich Morkovnik Anatolij Savelevich	RU2650877C1

RU 2 663 913 C1

Authors

Danilenko Valerij Nikolaevich

Bekker Olga Borisovna

Morozov Aleksej Sergeevich

Radchenko Evgenij Valerevich

Palyulin Vladimir Aleksandrovich

Malykhin Maksim Denisovich

Dates

2018-08-13—Published

2016-11-17—Filed